Interestingly, we found that ABZ treatment significantly decreased the tumor PD-L1 level (figure 1N, O) but did not affect the levels of PD-1 and CTLA-4 on CD8+ T cells (online supplemental figure 2H, I). The gene discussed is CD8A; the disease is neoplasm.